Skip to main content
Cancer Management and Research logoLink to Cancer Management and Research
. 2019 Jan 15;11:691. doi: 10.2147/CMAR.S198251

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum]

PMCID: PMC6339639  PMID: 30697065

Obasi TC, Braicu C, Iacob BC, et al. Cancer Manag Res. 2018;10:5709–5724.

On page 5717, there were errors in Figure 5A images and caption: the magnification is 40×, not 20×, and images 4A4 for Caski cells and 4A3 and 4A4 for Bu25TK cells have been replaced. The correct details follow.

Figure 5.

Figure 5

BCL-2 and VEGF protein expression quantification.

Notes: (A) Confocal microscopy for BCL-2 immunostaining for control and 4A3- and 4A4-treated Caski and Bu25TK cells for 48 hours post treatment in eight-well chamber slides (40× magnification). (B) VEGF quantification from cell culture medium was performed using ELISA for same experimental groups at 48 hours post treatment. *P≤0.05; **P≤0.01; ***P≤0.001.


Articles from Cancer Management and Research are provided here courtesy of Dove Press

RESOURCES